As of 2026-03-28, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 16.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.75 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is -19.8%.
The range of the Relative Valuation is 7.66 - 28.76 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.5x | 10.4x |
| Forward P/E multiples | 9.9x - 18.3x | 12.3x |
| Fair Price | 7.66 - 28.76 | 16.64 |
| Upside | -63.1% - 38.6% | -19.8% |
| Date | P/E |
| 2026-03-27 | 9.05 |
| 2026-03-26 | 9.36 |
| 2026-03-25 | 9.60 |
| 2026-03-24 | 9.14 |
| 2026-03-23 | 9.15 |
| 2026-03-20 | 9.04 |
| 2026-03-19 | 9.03 |
| 2026-03-18 | 8.86 |
| 2026-03-17 | 9.11 |
| 2026-03-16 | 9.33 |
| 2026-03-13 | 8.99 |
| 2026-03-12 | 9.27 |
| 2026-03-11 | 9.58 |
| 2026-03-10 | 9.83 |
| 2026-03-09 | 9.85 |
| 2026-03-06 | 9.66 |
| 2026-03-05 | 9.77 |
| 2026-03-04 | 10.20 |
| 2026-03-03 | 9.81 |
| 2026-03-02 | 9.95 |
| 2026-02-27 | 10.71 |
| 2026-02-26 | 10.74 |
| 2026-02-25 | 10.89 |
| 2026-02-24 | 10.72 |
| 2026-02-23 | 10.78 |
| 2026-02-20 | 10.46 |
| 2026-02-19 | 10.61 |
| 2026-02-18 | 10.12 |
| 2026-02-17 | 10.01 |
| 2026-02-13 | 9.61 |
| 2026-02-12 | 9.42 |
| 2026-02-11 | 9.80 |
| 2026-02-10 | 9.90 |
| 2026-02-09 | 10.12 |
| 2026-02-06 | 10.27 |
| 2026-02-05 | 10.23 |
| 2026-02-04 | 10.57 |
| 2026-02-03 | 10.80 |
| 2026-02-02 | 11.39 |
| 2026-01-30 | 10.96 |
| 2026-01-29 | 11.21 |
| 2026-01-28 | 11.17 |
| 2026-01-27 | 11.42 |
| 2026-01-26 | 11.71 |
| 2026-01-23 | 11.70 |
| 2026-01-22 | 12.00 |
| 2026-01-21 | 11.67 |
| 2026-01-20 | 11.46 |
| 2026-01-16 | 11.33 |
| 2026-01-15 | 11.57 |